AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05854368 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Additional blood collection as part of routine care
Description: Collection of an additional blood volume (10mL) as part of a blood sampling performed during routine care or specific for the research if not part of routine care.
Study NCT05053425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: given po.
Study NCT05053425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: given sc.
Study NCT05854368 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood collection
Description: Blood sample collection (10 mL)
Study NCT06497270 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Theca and Granulosa Cell Isolation
Description: These patients will receive standard procedure during the risk reducing surgery but their ovaries will be used to extract theca and granulosa cells which will be used for the 3D bioprinted device's realisation.
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Lenacapavir (LEN)
Description: Tablets administered orally without regard to food
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) Lenacapavir (LEN)
Description: Administered via SC injections
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF
Description: Tablets administered orally
Study NCT05053425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cladribine
Description: given ivgtt.
Study NCT05053425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: given sc or ivgtt.
Study NCT05053425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: given ivgtt.
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TDF
Description: Tablets administered orally
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo SC LEN
Description: Administered via SC injections
Study NCT05300269 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1701；Capecitabine；Oxaliplatin
Description: Radiation: Radiation therapy 50.4Gy in 28 fractions to the pelvis on Days 1-5 every week. Drug: Capecitabine Capecitabine 825mg/m\^2 orally twice daily (bid) 5 days/week during radiotherapy.~Drug:SHR-1701 Drug: Capecitabine (XELOX) Capecitabine 1000mg/m\^2 orally twice daily (bid) day1-day14, q3w. Drug: Oxaliplatin Oxaliplatin 130mg/m\^2, day1, iv, q3w
Study NCT06128993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcoronary cooling and dilution
Description: Transcoronary cooling and dilution
Study NCT06128993 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of care
Description: Routine clinical care
Study NCT05603091 — intervention group
Intervention type: PROCEDURE
Intervention: cryoablation of pulmonary veins
Description: Procedures are guided by pressure waveforms analysis, which are obtained by connecting the internal lumen of the catheter through the lateral port of the hemostatic valve attached to the catheter, to a pressure transducer connected in turn to a heparinized saline serum bag and to the cryoablation console.
Study NCT06419829 — intervention group
Intervention type: OTHER
Intervention: psychoprophylactic program aimed at normalizing body weight through medical training
Description: Based on the assessment of body weight and composition, a 12-week physiophylactic program will be carried out, adapted to the age and gender of the subjects. The program will be carried out twice a week for 30 to 60 minutes (depending on the group). The basis of the program will be the implementation of exercises that reduce fat mass, increase the flexibility and productivity of muscle mass. The classes will be conducted as part of medical training with a training load increasing to at least 85% of HR Max.~The project will include theoretical classes for parents, children and seniors on eating habits, a proper age-appropriate diet, diet changes depending on the subject's health condition and physical activity, and the impact of diet on the process of puberty, adulthood and aging.
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM Oral LEN
Description: Tablets administered orally
Study NCT06419829 — intervention group
Intervention type: OTHER
Intervention: psychoprophylactic program aimed at improving body posture
Description: Based on the body posture assessment, a 12-week physiotherapy program will be carried out, adapted to the age and gender of the subjects. The program will be carried out twice a week for 30 to 60 minutes (depending on the group). The basis of the program will be the implementation of exercises that strengthen the muscle corset, reducing asymmetrical positioning, habitual and during the implementation of professional tasks. The classes will be conducted using medical training and resistance exercises.~The project will include theoretical classes for parents on sitting habits, the importance of physical activity in a child's development, the selection of footwear...
Study NCT06419829 — intervention group
Intervention type: OTHER
Intervention: psychoprophylactic program aimed at improving physical fitness
Description: Based on the assessment of physical fitness, a 12-week physiotherapy program will be carried out, adapted to the age and gender of the participants. The program will be carried out twice a week for 30 to 60 minutes (depending on the group). The basis of the program will be the implementation of exercises aimed at improving physical fitness, with particular emphasis on impaired motor skills. The classes will be conducted using functional training, resistance and stretching exercises, strengthening all muscle groups. In the case of children, special attention will be paid to the strength of the upper limbs, in the case of seniors, balance and coordination exercises will be introduced to improve time and space orientation. In all groups, the main goal is to improve functional fitness The project will include theoretical classes for parents, children and seniors on the importance of physical activity in the quality of life, in the process of maturation and aging.
Study NCT06419829 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Body composition assessment
Description: Body composition assessment will be carried out using the BIA method on an eight-electrode body composition analyzer from TAnita. They will be marked:~total mass, Total fat mass (FM) and segmental fat mass for five body segments: right leg (RL FM), Left leg (LL FM), right arm (RA FM), Left Arm (LA FM) trunk (TR FM).~total fat-free mass (FFM) and segmental for five body segments: right leg (RL FFM), Left leg (LL FFM), right arm (RA FFM), Left Arm (LA FMM) trunk (TR FMM).~Predicted total and segmental muscle mass (PMM) for five body segments: right leg (RL PMM), Left leg (LL PMM), right arm (RA PMM), Left Arm (LA PMM) trunk (TR PMM).~Total water content (TBW) including intracellular water (ICW) and extracellular water (ECW)
Study NCT06419829 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: assessment of body posture using the Kasperczyk method
Description: The Kasperczyk method was used to assess body posture, including physiotherapeutic assessment in both standing and sitting positions. The symmetry of the head, shoulders, spine curvatures, knee joints and foot positioning were assessed. The symmetry of the head position was examined in all three planes and in all movements, i.e. flexion - extension, right turn - left turn, rotation and combined movements. The lateral curvatures of the spine (scoliosis) and their physiological curvatures, their deepening or shallowing in all sections of the spine, as well as the mobility of the spine in all physiological planes of movement were assessed. The position of the shoulder and hip girdle was assessed, as well as the position of the upper limbs at the level of the knees and feet. The mobility of the lower and upper limbs was examined.
Study NCT06419829 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of physical fitness
Description: It depends on the age of the person being examined. In the case of children, the EUROFIT physical fitness test is carried out with modifications for age and gender. For the senior group, the Rikli and Jones test is used
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM F/TAF
Description: Tablets administered orally
Study NCT04994509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM F/TDF
Description: Tablets administered orally
Study NCT06419829 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Balance assessment
Description: Balance assessment using the Zebris platform Static measurement - with eyes open and closed, assessing the load on the limbs during standing expressed in %, Balance analysis measurement - with eyes open and closed, test in a standing position, barefoot. The measurement duration is 30 seconds and the break between measurements is 30-60 seconds.~Deflections of the center of gravity in the frontal and sagittal planes Length of the center of gravity swing path CoP - SPL \[cm\]. Inside the calculated ellipse lies 95% of the CoP location measurement data: amplitude, amplitude height, ellipse area (orientation of the direction of the ellipse's longitudinal axis relative to the platform's longitudinal axis, indicating clockwise rotation).
Study NCT05830838 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT
Study NCT05830838 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Image-Guided Adaptive Radiation Therapy
Description: Undergo daily adaptive online replanning for SBRT
Study NCT05830838 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05830838 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT05830838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05830838 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study NCT05270395 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mPal
Description: mPal's patient content includes a multi-component web-based tool with the following: (1) a brief educational video that seeks to educate patients about palliative care; (2) and assessment of palliative care knowledge; (3) assessment of palliative care needs; and (4) an assessment of whether patients would like to meet with palliative care or discuss palliative care and their palliative care needs with their oncology provider.~The provider-level component includes provider education on palliative care. The system-level component includes electronic health record modifications to facilitate palliative care discussions and referrals.
Study NCT05414409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Metformin is an oral medication that improves insulin sensitivity.
Study NCT06202235 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Both CKD Patients and Healthy Volunteers will undergo Magnetic Resonance Elastography (MRE) to evaluate liver and renal viscoelasticity. For CKD patients, blood tests for creatinine and cystatin C, along with blood pressure measurements, will be taken within a three-day window surrounding the MRE test. Additionally, CKD patients will undergo a renal biopsy to assess the extent of fibrosis
Study NCT05251558 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: The telerehabilitation platform is used to deliver the home exercise program.
Study NCT05251558 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Education Program
Description: The patient is given education about the points to be considered for the disease and the exercises to be applied.
Study NCT04876820 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Description: In the intervention arm, the patient meets with the pharmacist. Pharmaceutical intervention (H1) about anti-epileptic drugs prescribed will be done: information on when to take the medication, what to do if you forget to take it or vomit, and an explanation of adverse events. The aim is to improve medication adherence and patient knowledge. A report will be sent to the community pharmacist.~An assessment of medication adherence to antiepileptic drug by MPR at H1 3 months and 6 months (phone call to community pharmacist) will be done. The health insurance score will also be done.~An assessment of patient knowledge by a self-made knowledge questionnaire (10 items) at H1 in pre- post interview -, 3 and 6 months (phone call to patient) will be done.~An assessment of pharmacists' satisfaction about community hospital network by a satisfaction questionnaire will be done.
Study NCT04876820 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard of care
Description: An assessment of medication adherence to antiepileptic drug by MPR at the inclusion then 3 months and 6 months later will be done by a phone call to the community pharmacist. An assessment of patient knowledge by a self-made knowledge questionnaire (10 items) at the inclusion then 3 and 6 months later will be done by a phone call to the patient. The health insurance score will be also done during this call.
Study NCT04751656 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Steady Intervention
Description: Participants will be asked to weigh themselves daily via a smart scale that transmits weight data directly to the study team via the cellular network for 12 months. Every-other week, participants will be sent text messages providing brief feedback encouraging continued self-weighing. Moreover, if a small weight gain is observed, participants will be sent text messages aiming to engage them in commercial or community-based evidence-based weight management resources.
Study NCT04929548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib Maleate Tablets
Description: Addition of Pyrotinib in the EC phase to the standard treatment EC-THP regimen recommended by the guidelines.
Study NCT04604548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral administration of 100 mg KH176 twice daily
Description: Drug: KH176
Study NCT05609292 — intervention group
Intervention type: DEVICE
Intervention: observational
Description: Infants will get their temperature measured with the liquid crystal thermometer. We are not providing any interventions as they will be in the care of a healthcare team.
Study NCT06403397 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group: CEASE Care Package and Remember Me Tool
Description: Before the intervention, the intervention group will first undergo the 'Nurse Identification Form' and the 'Alarm Fatigue Scale'. The current root cause analysis of monitor alarms in the clinical setting will be conducted through the 'CEASE Care Package' and the 'Current Situation Analysis Form'. Each patient monitor in the intensive care unit will be observed and recorded by two observers for a period of 24 hours.The Monitor Alarm Control Tool - Remember Me will be attached beneath each monitor to facilitate easier monitoring by nurses. Nurses are expected to use the tool for a period of 15 days. After intervention; Two observers will conduct a re-evaluation using the CEASE Care Package and the Current Status Analysis Form. Monitor alarms will be continuously assessed and recorded for 24 hours. Following the completion of this stage, the Alarm Fatigue Scale will be reapplied to the intervention group.
Study NCT04882202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Acetaminophen 1g IV every 6 hours for a weight > 50kg (maximum of 4g per 24 hours) or 15mg/kg every 6 hours for a weight \< 50kg (maximum of 75mg/kg per 24 hours)
Study NCT04882202 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline 100 ml (equal amount of acetaminophen) IV every 6 hours
Study NCT05661617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Nine Hole Peg Test, Purdue Pegboard Test, Box and Block Test
Description: Research participants were tested in one meeting after giving informed consent, answering a few short questions regarding health status and filling out a short questionnaire using the Czech extended version of the manual for the Nine Hole Peg Test, Purdue Pegboard Test and Box and Block Test, and always according to a predetermined order. Intentionally, all research participants from experimental group with a dominant right upper limb will be tested as if they were left-handed, and vice versa.~All research participants from normative study were tested normally according to the Czech extended manuals for those tests.
Study NCT05678881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose RLS103
Description: 8 mg CBD inhaled powder
Study NCT05678881 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo inhaled powder
Description: placebo inhaled powder
Study NCT05678881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose RLS103
Description: 4 mg CBD inhaled powder (open label)
Study NCT05535296 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Risk profile
Description: Compiliation of risk profile based on fitness, strength, mobility, balance, posture, physical activity level, weight and pain. Advice based on the above and support in goal-setting.
Study NCT05255367 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: (poly)phenols rich foods
Description: Prior to start the intervention (initial time of the study) the volunteers will follow their habitual diet during 30 days as a control period, and then they will start with the intervention period (baseline) following their habitual diet supplemented with (poly)phenol rich products during 60 days (after intervention).~At the beginning of the study (initial time), at the beginning of the intervention (baseline) and at the end of the intervention (after the intervention) with rich (poly)phenols foods, biological samples (blood, urine and feces) and anthropometric measurements will be taken. In addition, the participants will record the food intake weekly with a 24 h dietary-recall form.
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-5718
Description: Tablets administered orally
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to match GS-5718
Description: Tablets administered orally
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to match GS-5718
Description: Tablets administered orally
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo to match GS-5718
Description: Tablets administered orally
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tofacitinib 5 mg
Description: Tablets administered orally
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to match Tofacitinib
Description: Tablets administered orally
Study NCT05165771 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to match Tofacitinib
Description: Tablets administered orally
Study NCT05682716 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Controlled low central venous pressure (CLCVP) technology
Description: Controlled low central venous pressure (CLCVP) technology: after cardiopulmonary bypass, pumping nitroglycerin (0.2-1 ug/kg \* min) and other methods until the end of surgery to maintain the central venous pressure below 10 mmHg.
Study NCT05682716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Description: nitroglycerin (0.2-1 ug/kg \* min)
Study NCT05483777 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRF
Description: Platelet-rich fibrin preparation and application technique will applied to the experimental group.
Study NCT05764785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MentorPRO
Description: MentorPRO is a novel application and web platform for mentoring programs that allows students to set goals, track their challenges, and find just-in time resources, while connecting to a mentor for personalized support and progress monitoring.
Study NCT04947423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DPI-386 Nasal Gel
Description: Subjects will self-administer DPI-386 Nasal Gel or Placebo
Study NCT04947423 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will self-administer DPI-386 Nasal Gel or Placebo
Study NCT05510752 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Group Therapy
Description: CBGT is a 6-week group that meets weekly for 2-hours per week, where participants learn cognitive and behavioural techniques to enhance coping skills for their everyday anxieties.
Study NCT05510752 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: Psychoeducation is the most common non-pharmacological treatment for perinatal distress, where participants learn about healthy infant milestones and how to implement self-care in their daily lives, which in turn reduces distress during the perinatal period.
Study NCT05199220 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Participant must complete a questionnaire about injury during crossfit practice
Study NCT05222607 — intervention group
Intervention type: DRUG
Intervention: IncobotulinumtoxinA
Description: IncobotulinumtoxinA injections for aesthetic indications.
Study NCT06240091 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DISC-MA
Description: DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.
Study NCT05384353 — intervention group
Intervention type: OTHER
Intervention: [18F]-SynVesT-1
Description: PET radioligand binding to synaptic vesicle protein 2A as a proxy for synaptic density